Drug profile · INN
calcium
ISOPAQUE 280
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
calcium (ISOPAQUE 280) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12351609
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
granted -
US 12257224
Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker
granted -
US 12202832
Heterocyclic compounds having a calcium-sensing receptor antagonistic activity
granted -
US 12077502
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11773138
Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
granted -
US 11649207
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11427540
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11358947
Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A
granted
Frequently asked questions
What is calcium?
calcium (ISOPAQUE 280) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for calcium?
ISOPAQUE 280 is a marketed brand name for calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calcium?
calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.